Vir Biotechnology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
VIR Key Statistics
Stock Snapshot
As of today, Vir Biotechnology(VIR) shares are valued at $9.35. The company's market cap stands at 1.47B, with a P/E ratio of -3.02.
During the trading session on 2026-03-05, Vir Biotechnology(VIR) shares reached a daily high of $9.55 and a low of $9.27. At a current price of $9.35, the stock is +0.8% higher than the low and still -2.1% under the high.
Trading volume for Vir Biotechnology(VIR) stock has reached 70.11K, versus its average volume of 11.01M.
The stock's 52-week range extends from a low of $4.16 to a high of $10.94.
The stock's 52-week range extends from a low of $4.16 to a high of $10.94.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.